Twitter smoking cessation program helps smokers quit
the ONA take:
According to findings published recently in the Journal of Medical Internet Research, researchers from University of California, Irvine in Irvine, California, and Stanford University in Stanford, California, have found that when participants of a smoking cessation program tweet each other regularly on Twitter, they are more successful at stopping smoking.
For the program, called Tweet2Quit, participants communicated online via Twitter for 100 days, received a free supply of nicotine patched, and received daily automated text messages from trained counselors.
Participants were also encouraged to use an internet-based guide to develop a smoking cessation plan and to tweet their 20-person groups at least once daily about their progress.
Researchers found that 78% of two consecutive 20-person Tweet2Quit group tweeted their fellow study subjects at least once daily during the 100 days.
Results showed that the first group had a 42% smoking cessation rate compared with 75% in the second group, which benefited from changes to the automessaging process.
The findings suggest that incorporating social media-delivered automessages from trained counselors in as effective approach in promoting smoking cessation by encouraging participants to tweet about their progress, thereby holding themselves more accountable for quitting.
When participants of a smoking cessation program tweet each other regularly on Twitter, they are more successful at stopping smoking.
- Immunotherapy May Benefit Some Patients with Papillary Thyroid Carcinoma
- New Study Questions Standard Dosage for Treating Metastatic Non-Small Cell Lung Cancer
- Clinical Trials May Benefit Oncology Patients
- Breast Cancer Overdiagnosis Also a Result of Screening Mammography Programs
- Prostate-specific PET and CT Imaging Improves Detection of Disease and Patient Care
- Survivorship Care Plans: Providing A Blueprint for Health Care After Cancer
- Multifaceted Role of the Nurse Navigator Includes Palliative, Supportive Care
- Cancer Recurrence Fear Reduced by Novel Psychological Intervention
- Patient Navigators Found to Boost Lung Cancer Screening Rates
- Breast Cancer Diagnosis and Nurse Navigation Survey
- Novel 3D Marker Reduces Radiation, Improves Cosmesis in Breast Conserving Surgery
- Rates at Some Milestones May Indicate Clinical Trial Results for Immunotherapeutics
- Cancer Risks for BRCA1/2 Mutation Carriers Determined by Age, Family History, Mutation Location
- Long-Term Use of TPO Receptor Agonist Safe in CLL-Associated Immune Thrombocytopenia
- Savolitinib Active, Tolerable in Subset of Advanced Papillary Renal Cell Cancer
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|